Lv1
100 积分 2024-02-28 加入
CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer
29天前
已关闭
Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial
29天前
已完结
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial
29天前
已完结
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
29天前
已完结
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
29天前
已完结
1319O Perioperative camrelizumab plus chemotherapy in locally advanced squamous cell carcinoma of the head and neck (CAMORAL): A multicenter, open-label, randomized, phase II Study
29天前
已关闭
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
1个月前
已完结
Recent advances in refinement of the NPC TNM staging system
2个月前
已完结
Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites
2个月前
已完结
Long‐term survival analysis of nasopharyngeal carcinoma by plasma Epstein‐Barr virus DNA levels
3个月前
已关闭
皖公网安备34019202002308
